欢迎
 

   亚太扑灭病毒性肝炎联盟系通过倡导政府政策改革

   从而减轻该地区病毒性肝炎所致影响之非营利性

   组织。

成立于2010年10月的亚太扑灭病毒性肝炎联盟(CEVHAP),系由多领域权威专家所组成,致力于倡导通过公共政策改革以降低病毒性肝炎对亚太区之危害。

CEVHAP系亚太地区首个该类型卫生组织,旨在成为各政府、非政府组织、学术专家、民间团体及患者间之沟通桥梁。

世界肝炎日世界卫生大会通过有关病毒性肝炎的决议 (WHA63.18)首次将病毒性肝炎确认为全球性医疗议题,并确立每年7月28日为「世界肝炎日」。
                           
>> 更多信息
FaLang translation system by Faboba
Connect with us     connect with CEVHAP           

nohep.logo_horizontal.jpg

NOhep is a global, grassroots movement aimed at bringing all stakeholders together to eliminate viral hepatitis by 2030. It has been developed to create global awareness of the disease, similar to the red ribbon for HIV/AIDS, and was launched in 2016. NOhep firmly positions itself at the forefront of the elimination conversation, showcasing exemplary leadership, fostering on-the-ground innovative solutions and taking action to support the policy changes needed to eliminate this cancer-causing illness by 2030. Being a part of NOhep means being part of the solution. (To find out more about the development of this exciting initiative, watch this short video: https://youtu.be/Oer-rGwnKZU

CAF badge

CEVHAP has been vetted and approved to receive tax-deductible donations and grants via CAF America.

If you are a US donor wishing to make a tax-deductible contribution to support us, please visit the “Give Now” page at CAF America’s website at www.cafamerica.org and following these steps:

1. Visit https://cafamerica.org

2. Click “Give Now”

3. “Give a single gift”

4. “Search and Give to organizations in the CAF America Database”

5. Type in “CEVHAP”

6. Click “Donate Now”

7. Fill out the form accordingly and click Submit

8. Enter credit card information and click Submit

9. Wait for the confirmation page – do not re-click submit or refresh the page as you may be additionally charged.

10. An e-mail confirmation will be sent to you for tax deduction purposes.

 

CEVHAP Activity Report Brochure EMAIL smaller Cover

>> 基本概况
病毒性肝炎
全球约有20亿乙肝病毒(HBV)携带者。
由该病毒所致之急性或慢性肝病,平均每
年夺取约60万人生命
如果未经有效治疗,患慢性丙肝及其他
进展性肝病(如肝硬化)之患者比例至2015
年将大幅提升百分之三十八。
目前并无丙肝预防疫苗问世,但约80%
患者可经有效针对性治疗而获痊愈
>> 视频录影资料
病毒性肝炎所致之全球性健康危害

CEVHAP主席陈定信教授